Catalyst Wire Dossier Catalyst Wire Dossier

Praluent

alirocumab · Sanofi/Regeneron
Drug timelines are a Plus or Pro feature.

33 regulatory and trial events tracked for Praluent, covering 2013-06-28 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

See pricing